Zhongchao ROE 2019-2025 | ZCMD

Current and historical return on equity (ROE) values for Zhongchao (ZCMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Zhongchao ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.018B $0.016B
Zhongchao Inc. is a provider of healthcare information, professional training and educational services to healthcare professionals under its MDMOOC platform and to the public under its Sunshine Health Forums platform. Zhongchao Inc. is headquartered in Beijing, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.732B 58.24
Tempus AI (TEM) United States $12.524B 0.00
Doximity (DOCS) United States $11.721B 48.51
Hims & Hers Health (HIMS) United States $9.384B 76.89
IRhythm Technologies (IRTC) United States $5.716B 0.00
Hinge Health (HNGE) United States $3.454B 0.00
Privia Health (PRVA) United States $2.943B 184.46
Heartflow (HTFL) United States $2.876B 0.00
Inspire Medical Systems (INSP) United States $2.435B 40.29
Enovis (ENOV) United States $1.624B 8.53
10x Genomics (TXG) United States $1.618B 0.00
Omnicell (OMCL) United States $1.605B 32.81
Schrodinger (SDGR) United States $1.373B 0.00
Azenta (AZTA) United States $1.355B 59.10
Clover Health Investments (CLOV) United States $1.338B 0.00
Phreesia (PHR) United States $1.334B 0.00
Claritev (CTEV) United States $1.021B 0.00
Evolent Health (EVH) United States $0.705B 0.00
Fulgent Genetics (FLGT) United States $0.683B 0.00
Talkspace (TALK) United States $0.568B 113.00
Butterfly Network (BFLY) United States $0.566B 0.00
Veradigm (MDRX) United States $0.545B 0.00
Standard BioTools (LAB) United States $0.431B 0.00
Zepp Health (ZEPP) Netherlands $0.402B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.320B 0.00
Carlsmed (CARL) United States $0.316B 0.00
TruBridge (TBRG) United States $0.289B 13.27
CapsoVision (CV) United States $0.225B 0.00
MDxHealth SA (MDXH) Belgium $0.220B 0.00
Outset Medical (OM) United States $0.210B 0.00
Health Catalyst (HCAT) United States $0.208B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.186B 0.00
KORU Medical Systems (KRMD) United States $0.183B 0.00
Nyxoah SA (NYXH) Belgium $0.171B 0.00
CareCloud (CCLD) United States $0.147B 8.07
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
NetraMark Holdings (AINMF) Canada $0.077B 0.00
Pulmonx (LUNG) United States $0.074B 0.00
American Well (AMWL) United States $0.066B 0.00
P3 Health Partners (PIII) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
Evaxion - (EVAX) Denmark $0.040B 0.00
111 (YI) China $0.037B 0.00
Precipio (PRPO) United States $0.033B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Lunai Bioworks (LNAI) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00